Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, Grillner L, Persson MAA: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607.
Garson JA, Ring CA, Tuke PW: Improvement of HCV genome detection with 'short' PCR products. Lancet 1991;338:1466-1467.
Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN: Confirmation of hepatitis C virus infection by new four-antigen recombinant immuno-blot assay. Lancet 1991;337: 317-319.
Van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, Lelie PN: Infectivity of bood seropositive for hepatitis C virus antibodies. Lancet 1990; 335:558-560.
Dow BC, Coote I, Munro F, McOmish F, Yap PL, Simmonds P, Follett EAC: Confirmation of hepatitis C virus antibody in blood donors. J Med Virol 1993;41:215-220.
Romeo R, Thiers V, Driss F, Berthelot P, Nalpas B, Brechet C: Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 1993;33:629-633.
Nishozono A, Hiraga M, Mifune K, Terao H, Fujioka T, Nasu M, Goto T, Misumi J-I, Moriyama M, Arakawa Y, Hayashi N, Esumi M, Shikata T: Correlation of serum antibody titers against hepatitis C virus core protein with clinical features by Western blot (immuno-blot) analysis using a recombinant vaccinia virus expression system. J Clin Microbiol 1993;31: 1173-1178.
Sayers MH, Gretch DR: Recombinant immunoblot and polymerase chain reaction testing in volunteer blood donors screened by a multi-antigen assay for hepatitis C virus antibodies. Transfusion 1993;33:809-813.
Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreno V: Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C. J Infect Dis 1994;170:669-673.
Hellström UB, Sylvan SPE, Decker RH, Sönnerborg A: Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993;39: 325-332.
Okamoto H, Tsuda F, Machida A, Munekata E, Akahane Y, Sugai Y, Mashiko K, Mitsui T, Tanaka T, Miyakawa M: Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection. Hepatology 1992;15:180-186.
Wroblewski F, Ladue JS: Serum glutamic pyruvic transaminase in cardiac and hepatic disease. Proc Soc Exp Biol Med 1956;91:569-571.
Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-724.
Urushihara A, Suzuki T, Matsumoto A, Tanaka E, Sodeyama T, et al: Quantitative assay for anti-HCV-core antibody in healthy individuals found anti-HCV positive during a mass screening. Int Hepatol Commun 1994;2:47-51.